Plain-English translation of NCT06955897 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Spinal Muscular Atrophy research guide →This study is designed to better understand fatigue and how people with spinal muscular atrophy experience tiredness during everyday activities, especially those being treated with nusinersen. While this medication has helped extend survival and improve movement, people still report struggling with tiredness and the ability to keep doing physical activities. This research aims to measure and understand that tiredness in a way that reflects real life.
Even though this medication has improved survival and motor function for people with spinal muscular atrophy, fatigue remains a significant problem in daily life. Researchers don't yet have a good way to measure how tiredness affects people's ability to do repetitive physical tasks, and they want to understand whether the medication's effectiveness changes over time between treatments.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic for assessments where researchers ask you questions about how tired you feel and watch you complete everyday physical activities like walking or sitting tasks. The study is designed specifically for people with spinal muscular atrophy and takes into account your current level of mobility. Researchers will measure your experience of fatigue and how it affects your ability to keep going with daily activities.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
United States